1.Development of a Clinical Practice Guideline Utilization System to Support Pharmacist Prescription Proposals:
Itsuko Ohno ; Nobuyo Suzuki ; Shihori Kawahara ; Yoshiaki Shikamura ; Yasunari Mano ; Tsugumichi Sato ; Shuji Shimada ; Keita Akagi ; Yoshi Shigeno ; Mitsue Saito ; Naoko Sugihira ; Masayo Komoda
Japanese Journal of Drug Informatics 2017;19(2):50-58
Objective: Pharmacists need to know at what positioning a drug is recommended in clinical practice guidelines when they make prescription proposals. However, the format of guidelines and the definition of recommendation grades differ between academic societies, making it difficult to comprehensively extract only the information one needs. Therefore, we developed a guideline utilization system to support prescription proposals by pharmacists.
Methods: We built a database comprised of clinical practice guidelines on pharmacological therapy for breast cancer and breast cancer-related conditions. FileMaker®was used in the development of the system.
Result: This system allows the comprehensive extraction of clinical questions and recommendations from multiple guidelines by means of standardized keywords.
Conclusion: This system supports prescription proposals by pharmacists when generating pharmacological therapy protocols or when in discussions with healthcare professionals as information on the positioning of therapeutic agents in different guidelines and recommended drugs is readily available.
2.Understanding the factors associated with initiation and adherence of osteoporosis medication in Japan: An analysis of patient perceptions.
Hajime ORIMO ; Masayo SATO ; Shuichi KIMURA ; Keiko WADA ; Xuelu CHEN ; Shigeto YOSHIDA ; Bruce CRAWFORD
Osteoporosis and Sarcopenia 2017;3(4):174-184
OBJECTIVES: This study aimed to identify factors associated with initiation and adherence of osteoporosis medication from a patient perspective. METHODS: A web-based survey was developed based on health behavior theories. Descriptive analyses were conducted for all survey items. Analyses in a structural equation modeling framework were conducted to identify factors associated with treatment initiation and adherence. RESULTS: Five hundred forty-five women completed the questionnaire. A majority were currently receiving medications for osteoporosis (n = 376, 69.0%) and 25.0% of these patients (n = 94) were considered adherent to their treatment. Knowledge was strongly associated with osteoporosis treatment initiation (standard error [SE], 0.58). Greater knowledge of disease was associated with increased likelihood of initiating medication. Medication complexity (SE, 0.49) and perceived susceptibility to fracture and loss of independence (SE, −0.37) were also associated with initiation. Perceived barriers (SE, −0.85) such as inconvenience, lack of efficacy and financial burden were observed to be the greatest obstacle to adherence. The greater the perceived barriers, the less likely patients were to adhere to medication. Patients' perception of self-efficacy (SE, 0.37) also affected adherence. The greater the patient perception of ability to independently manage their medication, the more likely they were to adhere to the medication. CONCLUSIONS: Different factors were found to be associated with initiation and adherence of osteoporosis medication. Patient knowledge of their disease and the perception of barriers were found to be the most influential. Empowering patients with the knowledge to better understand their disease and decreasing the perception of barriers through education initiatives may be effective in improving patient outcomes.
Education
;
Female
;
Health Behavior
;
Humans
;
Japan*
;
Osteoporosis*
;
Patient-Centered Care